Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Collegium Pharma (COLL)

Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 959,438
  • Shares Outstanding, K 32,250
  • Annual Sales, $ 566,770 K
  • Annual Income, $ 48,160 K
  • EBIT $ 193 M
  • EBITDA $ 341 M
  • 60-Month Beta 0.95
  • Price/Sales 1.66
  • Price/Cash Flow 2.71
  • Price/Book 4.02

Options Overview Details

View History
  • Implied Volatility 55.08% ( +10.09%)
  • Historical Volatility 38.71%
  • IV Percentile 59%
  • IV Rank 51.65%
  • IV High 83.66% on 05/21/24
  • IV Low 24.53% on 12/08/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 4
  • Volume Avg (30-Day) 20
  • Put/Call OI Ratio 0.33
  • Today's Open Interest 1,015
  • Open Int (30-Day) 972

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 1.38
  • Number of Estimates 4
  • High Estimate 1.49
  • Low Estimate 1.27
  • Prior Year 1.45
  • Growth Rate Est. (year over year) -4.83%

Price Performance

See More
Period Period Low Period High Performance
1-Month
28.97 +3.56%
on 11/18/24
38.51 -22.10%
on 10/21/24
-8.44 (-21.96%)
since 10/18/24
3-Month
28.97 +3.56%
on 11/18/24
42.29 -29.06%
on 10/07/24
-6.21 (-17.15%)
since 08/20/24
52-Week
25.16 +19.24%
on 11/29/23
42.29 -29.06%
on 10/07/24
+4.41 (+17.23%)
since 11/20/23

Most Recent Stories

More News
Collegium to Participate in Upcoming Investor Conferences

COLL : 30.00 (+0.84%)
Is the Options Market Predicting a Spike in Collegium Pharmaceutical (COLL) Stock?

Investors in Collegium Pharmaceutical, Inc. COLL need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 20, 2024 $20 Put had some of the highest implied...

COLL : 30.00 (+0.84%)
Collegium Pharmaceutical: Q3 Earnings Snapshot

Collegium Pharmaceutical: Q3 Earnings Snapshot

COLL : 30.00 (+0.84%)
Collegium Reports Record Third Quarter 2024 Financial Results

COLL : 30.00 (+0.84%)
Collegium Appoints Vikram Karnani as Chief Executive Officer

COLL : 30.00 (+0.84%)
Corcept Therapeutics Stock Surges 61% in 2024: A Must Buy?

Corcept Therapeutics Incorporated CORT has been having a fabulous 2024, with its share price increasing 60.5% year to date as of Nov. 5, 2024.This company engages in the discovery and development of drugs...

CORT : 56.09 (+3.29%)
COLL : 30.00 (+0.84%)
IONS : 35.40 (+4.89%)
Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024

COLL : 30.00 (+0.84%)
Collingwood Closes Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

COLL : 30.00 (+0.84%)
Collingwood Announces Non-Brokered Private Placement and Board Appointment

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

COLL : 30.00 (+0.84%)
Collegium Pharmaceutical: Q2 Earnings Snapshot

Collegium Pharmaceutical: Q2 Earnings Snapshot

COLL : 30.00 (+0.84%)

Business Summary

Collegium Pharmaceutical Inc. is a specialty pharmaceutical company. It develops and commercializes prescription and over-the-counter pharmaceuticals for the treatment of central nervous system, respiratory and skin related disorders. The Company's product candidate consists of COL-195, COL-196, COL-171,...

See More

Key Turning Points

3rd Resistance Point 30.82
2nd Resistance Point 30.43
1st Resistance Point 30.21
Last Price 30.00
1st Support Level 29.60
2nd Support Level 29.21
3rd Support Level 28.99

See More

52-Week High 42.29
Fibonacci 61.8% 35.74
Fibonacci 50% 33.72
Fibonacci 38.2% 31.70
Last Price 30.00
52-Week Low 25.16

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar